Research and drug development consultancy - translating cutting-edge science into medicinal products for patient benefit. Offices in the US, UK and Europe.
At Boyds, our goal is to translate great science into medicinal products for the benefit of patients. Visit https://t.co/LvrR3szmfU to find out how we can support the translation and development of your research ideas into therapeutics.
Exciting news! 🎉 We are thrilled to announce Boyds has been named as a finalist in the Business Support category of the @Bionow Awards 2023.
Read more: https://t.co/4nmQHgC4uL
The latest episode of Conversations in Drug Development is out now. We are kickstarting the year with a discussion into the trends and predictions for the drug development space in 2024, with of Boyds, Professor Alan Boyd 🎙️
Listen on #spotify#applepocasts#Amazonmusic
In our recent episode of Conversations in Drug Development, Harriet Edwards and Dr Patrick Ginty dive into the fascinating world of off-the-shelf cell therapies and their impact on regulatory considerations.
Listen here: https://t.co/rbzmDHpwAQ
The TOPRA #RegAwards23 saw the Boyds team take home two awards, with our regulatory affairs team crowned winners of the Futures Award and our Senior Director of Regulatory Affairs Katherine Bowen awarded the Inspiration Award.👏
Read more on our website: https://t.co/X5PADHsFLY
We are delighted to announce the appointment of Monica Pianella as Associate Director of Regulatory Affairs.
Learn more about Monica's career background in our news story here: https://t.co/CFJuqMShbv
#regulatoryaffairs#regulation#drugdevelopment
In this episode of Conversations in Drug Development, Dr Katherine Bowen and Dr Julie Warner delve deep into the ever-evolving world of oncology drug development and the regulatory landscape in the US and EU.
We are incredibly excited to announce the launch of our new podcast 'Conversations in Drug Development'. Now available on all the main podcast streaming platforms. Visit https://t.co/rbzmDHpwAQ to listen. #podcast#drugdevelopment#oncology
On #AdaLovelaceDay, Dr Karen Mullen, our Chief Medical Officer, discusses what inspired her to pursue a #STEM career, her tips for overcoming adversity, and ways to encourage more women to consider STEM careers. 🔬🧬
https://t.co/qe26gCFaij
#ALD23@FindingAda
On The Hot Desk today Claire Smith, MD of Evolve Together Ltd gives ua some Listener Advice about the Sales Cycle, and Professor Alan Boyd, managing director of Alan Boyd Consultants Ltd who discusses how the development of genetic medicines is progressing across the globe.
Yesterday, the UK government announced that the UK is to rejoin the EU’s flagship scientific research scheme, #Horizon.
Professor Alan Boyd , responds to the announcement: https://t.co/PpPjyTDyRj
#Bionow Member @boydconsultants has bolstered its service offering with the launch of a new in-house #regulatory operations service that will enable the company to support the full lifecycle of its clients’ #DrugDevelopment projects.
Read more: https://t.co/0Q2lZ6oak5
A Mutual Recognition Agreement (#MRA) between Switzerland and the USA in the area of Good Manufacturing Practice (#GMP) for medicinal products came into force with effect from 27 July.
Read more: https://t.co/hSgxF74gRk
Boyds has a wealth of experience in clinical study management, and in this blog, Dr Karen O'Hanlon sets out the approach the team follows to help maximise trial success.
Read the blog: https://t.co/SCWUXJ8ApD
We're delighted to announce a brand new relationship with @bougheydistltd and @boydconsultants
Check out the full story on our website ➡️ https://t.co/uJfcmdNGb3
We are delighted to congratulate Boyds’ Chief Medical Officer, Dr Karen Mullen on being awarded Fellowship of the Royal College of Physicians.
Read the full announcement here: https://t.co/d1VGAm3knQ
Ami Patel will be attending this week's educational symposium Cellicon Valley 23 - The Future of Cell and Gene Therapies @PennMDForum.
Find out more here:
https://t.co/TuqzDCE7zJ
#celltherapy#genetherapy